[1]
Ebata S., Et al., Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial, Lancet Rheumatol., 3, pp. E489-E497, (2021)
[1]
Ebata S., Et al., Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial, Lancet Rheumatol., 3, pp. E489-E497, (2021)